# Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

> **NCT01722604** · PHASE3 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 258 (actual)

## Conditions studied

- Glaucoma
- Open Angle or Ocular Hypertension

## Interventions

- **DRUG:** brinzolamide 1% ophthalmic suspension
- **DRUG:** Azopt 1%

## Key facts

- **NCT ID:** NCT01722604
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01722604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01722604, "Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01722604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*